Search Results - "PERTL, Ursula"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth by Reisfeld, Ralph A, Niethammer, Andreas G, Xiang, Rong, Becker, Jürgen C, Wodrich, Harald, Pertl, Ursula, Karsten, Gabriele, Eliceiri, Brian P

    Published in Nature medicine (01-12-2002)
    “…Tumor cells are elusive targets for immunotherapy due to their heterogeneity and genetic instability. Here we describe a novel, oral DNA vaccine that targets…”
    Get full text
    Journal Article
  2. 2

    In vivo Activity in a Catalytic Antibody-Prodrug System: Antibody Catalyzed Etoposide Prodrug Activation for Selective Chemotherapy by Shabat, Doron, Lode, Holger N., Pertl, Ursula, Reisfeld, Ralph A., Rader, Christoph, Lerner, Richard A., Barbas, Carlos F.

    “…Effective chemotherapy remains a key issue for successful cancer treatment in general and neuroblastoma in particular. Here we report a chemotherapeutic…”
    Get full text
    Journal Article
  3. 3

    Histone H2A-Mediated Transient Cytokine Gene Delivery Induces Efficient Antitumor Responses in Murine Neuroblastoma by Balicki, Danuta, Reisfeld, Ralph A., Pertl, Ursula, Beutler, Ernest, Lode, Holger N.

    “…A major goal of cancer immunotherapy is the induction of a cell-mediated antitumor response in poorly immunogenic malignancies. We tested the hypothesis that…”
    Get full text
    Journal Article
  4. 4

    Protective Immunity against Human Carcinoembryonic Antigen (CEA) Induced by an Oral DNA Vaccine in CEA-transgenic Mice by RONG XIANG, SILLETTI, Steve, LODE, Holger N, DOLMAN, Carrie S, RUEHLMANN, J. Michael, NIETHAMMER, Andreas G, PERTL, Ursula, GILLIES, Stephen D, PRIMUS, F. James, REISFELD, Ralph A

    Published in Clinical cancer research (01-03-2001)
    “…Peripheral T-cell tolerance toward human carcinoembryonic self-antigen (CEA) was broken in CEA-transgenic C57BL/6J mice by an oral CEA-based DNA vaccine. This…”
    Get full text
    Journal Article Conference Proceeding
  5. 5
  6. 6

    A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth by Niethammer, A G, Xiang, R, Becker, J C, Wodrich, H, Pertl, U, Karsten, G, Eliceiri, B P, Reisfeld, R A

    Published in Nature medicine (01-12-2002)
    “…Tumor cells are elusive targets for immunotherapy due to their heterogeneity and genetic instability. Here we describe a novel, oral DNA vaccine that targets…”
    Get full text
    Journal Article
  7. 7

    IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy by Pertl, U, Luster, A D, Varki, N M, Homann, D, Gaedicke, G, Reisfeld, R A, Lode, H N

    Published in The Journal of immunology (1950) (01-06-2001)
    “…The successful induction of T cell-mediated protective immunity against poorly immunogenic malignancies remains a major challenge for cancer immunotherapy…”
    Get full text
    Journal Article
  8. 8

    Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma by Pertl, Ursula, Wodrich, Harald, Ruehlmann, J. Michael, Gillies, Stephen D., Lode, Holger N., Reisfeld, Ralph A.

    Published in Blood (15-01-2003)
    “…The successful induction of a T-cell–mediated tumor-protective immunity against poorly immunogenic malignancies remains a major challenge for cancer…”
    Get full text
    Journal Article
  9. 9

    MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma by RUEHLMANN, J. Michael, RONG XIANG, NIETHAMMER, Andreas G, YI BA, PERTL, Ursula, DOLMAN, Carrie S, GILLIES, Stephen D, REISFELD, Ralph A

    Published in Cancer research (Chicago, Ill.) (01-12-2001)
    “…The induction of a CTL response capable of eradicating disseminated tumor metastases and the establishment of a persistent tumor-protective immunity remain…”
    Get full text
    Journal Article
  10. 10

    Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction by Lode, H N, Xiang, R, Pertl, U, Förster, E, Schoenberger, S P, Gillies, S D, Reisfeld, R A

    Published in The Journal of clinical investigation (01-06-2000)
    “…The induction of tumor-protective immunity against malignancies remains a major challenge in cancer immunotherapy. A novel, humanized…”
    Get full text
    Journal Article
  11. 11

    Histone H2A-mediated transient cytokine gene delivery induced efficient antitumor responses in murine neuroblastoma by Balicki, Danuta, Reisfeld, Ralph A, Pertl, Ursula, Beutler, Ernest, Lode, Holger N

    “…A major goal of cancer immunotherapy is the induction of a cell-mediated antitumor response in poorly immunogenic malignancies. We tested the hypothesis that…”
    Get full text
    Journal Article
  12. 12
  13. 13

    What to do with targeted IL-2 by Lode, H N, Xiang, R, Perri, P, Pertl, U, Lode, A, Gillies, S D, Reisfeld, R A

    Published in Drugs of today (Barcelona, Spain : 1998) (01-05-2000)
    “…A common strategy in immunotherapy of cancer is the induction of an increased immunogenicity of syngeneic malignancies. A novel approach to achieve this goal…”
    Get full text
    Journal Article
  14. 14